Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Gift of Life Donor Program Leads U.S. in Organ Donation for 13th Consecutive Year 2021-01-05 20:43
Global Cord Blood Announces NHC Policy Update 2021-01-05 20:30
Huami Enters in Definitive Agreement to Acquire a Minority Stake in Jiangsu Yitong High-Tech Co., Ltd. to expand the healthcare ecosystem for Chinese market 2021-01-05 20:05
Chiauranib, an Anti-tumor Drug Developed by Chipscreen, is Given CDE "Breakthrough Therapy Designation" 2021-01-05 17:49
Bay Materials Obtains Patents to Protect Innovative Clear-Aligner Material Zendura™ FLX 2021-01-05 17:15
Terumo Enters 100th Anniversary Year 2021-01-05 15:00
Y-Biologics signed License Agreement with 3D Medicines for T cell bispecific engager in Greater China territory 2021-01-05 09:00
Ascentage Pharma Announces its 9th Orphan Drug Designation from the US FDA in 2020, Setting a Record for Chinese Biopharmaceutical Companies 2021-01-05 08:32
Antengene Announces Submission of IND Application in China for a Global Phase 3 Trial of ATG-010 (Selinexor) in Advanced or Recurrent Endometrial Cancer 2021-01-05 08:00
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics' Newly Approved Libmeldy(TM) 2021-01-04 22:30
Regent Pacific Announces Key Progresses On FORTACIN(TM) / SENSTEND(TM) - Solution to Premature Ejaculation 2021-01-04 21:30
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China 2021-01-04 21:00
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021" 2021-01-04 21:00
Happiness Biotech Announces Registered Direct Offering of up to 4.2 Million Ordinary Shares to Strategic Investors 2021-01-04 21:00
CIMC Enric's Subsidiary Deploys Vaccine Storage Market To Carry out R&D of Cryogenic Liquid Nitrogen Biological Container 2021-01-04 16:23
Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL 2021-01-04 08:00
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib 2020-12-31 22:38
Ping An Ranks #1 in Top 100 Global Digital Health Patents for 2018-2020 2020-12-31 20:15
ImmVira Announces Series C Financing with Leading Specialist Investors 2020-12-31 19:29
Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate 2020-12-31 10:42
1 850 851 852 853 854 1776